Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation
NCT03738943Phase 1Completed
- Sponsor
- Colorado State University
- Start
- Feb 2019
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 1, randomised trial (3 arms), sponsored by Colorado State University. Primary endpoint: Vascular Conductance. Started Feb 2019; status: completed.
Beyond the preview
Go deeper on NCT03738943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738943.